Skip to navigation Skip to content

Clinical Trial: Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS

Share

Details
Type of MS: RRMS
Treatment mode of action: To reduce erythema, edema and pain
Number of Subjects: 28
Medication: warm and cold compress
Location: Washington
Institutions:

Evergreen Health Nueroscience Institute

Contact Information
Carey Gonzales
425.899.5374
CLGonzales@evergreenhealth.com

Funding:

Evergreen Health Nueroscience Institute

Description

A pilot study of warm and cold compress to reduce injection site erythema due to peginterferon beta-1a in multiple sclerosis.

Share